<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">YM</journal-id><journal-title-group><journal-title>Yangtze Medicine</journal-title></journal-title-group><issn pub-type="epub">2475-7330</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ym.2017.13018</article-id><article-id pub-id-type="publisher-id">YM-79350</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Prevalence of Coinfection with Malaria and HIV among Children in Yaound&#233;, Cameroon: A Cross-Sectional Survey Performed in Three Communities in Yaound&#233;
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tebit</surname><given-names>E. Kwenti</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emilienne</surname><given-names>Edo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Besong</surname><given-names>S. Ayuk</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tayong</surname><given-names>D. B. Kwenti</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Microbiology and Parasitology, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Department of Medical Laboratory Sciences, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Regional Hospital of Buea, Buea, Cameroon</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>kwentitebit@yahoo.com(TEK)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>09</month><year>2017</year></pub-date><volume>01</volume><issue>03</issue><fpage>178</fpage><lpage>188</lpage><history><date date-type="received"><day>28,</day>	<month>July</month>	<year>2017</year></date><date date-type="rev-recd"><day>24,</day>	<month>September</month>	<year>2017</year>	</date><date date-type="accepted"><day>27,</day>	<month>September</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Malaria and HIV are endemic in Cameroon. But data on the prevalence of coinfection with malaria and HIV in Cameroonian children are essentially absent. This study was aimed at determining the prevalence of coinfection with malaria and HIV among children in Yaound&#233;, so as to advice control policies. 
  Methods: In a cross-sectional survey, children (≤15 years) were recruited from 3 communities in Yaound&#233; namely: Efoulan, Biyem-assi and Cit&#233;-verte. A semi-structured questionnaire was used to collect demographic data. Participants were screened for malaria parasites by the examination of Giemsa-stained blood films meanwhile participants were screened for HIV following Cameroon’s national algorithm. The Pearson’s chi-square test was performed as part of the statistical analyses. Statistical significance was set at p &lt; 0.05.
   Result: Three hundred and ten (310) children took part in the study. The mean age (&#177;SD) of the participants was 75.64 (&#177;63.23) months and a majority of them were males (56.1%). The prevalence was 19.7%, 4.8% and 1.2% for malaria, HIV, and coinfection with malaria and HIV respectively. The prevalence of malaria was associated with age (p = 0.009) meanwhile the prevalence of HIV was associated with study site (p = 0.024). 
  <em>Plasmodium falciparum</em> was the only species identified as causing malaria in the target population. 
  Conclusion: A substantial prevalence of malaria, HIV and coinfection with malaria and HIV was observed in this study. Efforts should be strengthened to control and eventually eliminate these diseases in the target population.
 
</p></abstract><kwd-group><kwd>Malaria</kwd><kwd> HIV</kwd><kwd> Coinfection</kwd><kwd> Plasmodium falciparum</kwd><kwd> Prevalence</kwd><kwd> Children</kwd><kwd>  Yaound&#233;</kwd><kwd> Cameroon</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Malaria is a mosquito-borne infectious disease affecting humans and other animals. Globally there were an estimated 212 million cases of malaria and 429,000 deaths attributed to malaria in 2015 [<xref ref-type="bibr" rid="scirp.79350-ref1">1</xref>] . The incidence rate of malaria is estimated to have decreased by 41% globally between 2000 and 2015, meanwhile the malaria mortality rates have declined by 62% within the same timeframe [<xref ref-type="bibr" rid="scirp.79350-ref1">1</xref>] . The majority of cases and deaths attributed to malaria occur in sub-Saharan Africa (SSA) [<xref ref-type="bibr" rid="scirp.79350-ref1">1</xref>] . Although there has been a decline in malaria recently, malaria still remains a significant cause of morbidity and mortality in SSA, claiming the live of a child every 2 minutes [<xref ref-type="bibr" rid="scirp.79350-ref2">2</xref>] . In Cameroon, malaria is a major cause of morbidity and mortality among children [<xref ref-type="bibr" rid="scirp.79350-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref5">5</xref>] . Malaria is caused by parasitic protozoans of the genus Plasmodium. Five species are known to cause disease in humans namely; Plasmodium ovale, P. malariae, P. knowlesi, P. vivax, and P. falciparum, with the latter being the most virulent species accounting for the majority of cases and deaths attributed to malaria. Like in other SSA countries, P. falciparum is the predominant species in Cameroon [<xref ref-type="bibr" rid="scirp.79350-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref7">7</xref>] .</p><p>SSA also has the highest burden of the human immunodeficiency virus (HIV). In 2014, there were 25.8 million people living with HIV/AIDS (PLWHA) in SSA [<xref ref-type="bibr" rid="scirp.79350-ref8">8</xref>] , accounting for approximately 70% of the global total. In Cameroon the overall prevalence of HIV is estimated at 4.5% [<xref ref-type="bibr" rid="scirp.79350-ref9">9</xref>] . There are about 39,000 children (&lt;14 years) living with HIV in Cameroon and about 310,000 children orphaned due to AIDS [<xref ref-type="bibr" rid="scirp.79350-ref9">9</xref>] . HIV in Cameroon affects typically the poor and less privileged [<xref ref-type="bibr" rid="scirp.79350-ref10">10</xref>] .</p><p>Because of the presence of all the factors favouring transmission in SSA including poverty, malaria and HIV are common in the region. Due to their overlapping distribution, coinfection with malaria and HIV is therefore bound to be common in the area. Coinfection with malaria and HIV is thought to have a synergistic effect, with studies reporting that repeated infection with malaria leads to a more rapid decline in CD4<sup>+</sup> T cells overtime, meanwhile malaria coinfection with HIV results in more episodes of symptomatic malaria [<xref ref-type="bibr" rid="scirp.79350-ref11">11</xref>] , and more episodes of severe or complicated malaria including death in both children and adults [<xref ref-type="bibr" rid="scirp.79350-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref16">16</xref>] . The risk of severe anaemia is also higher in HIV patients coinfected with malaria compared to HIV patients without malaria [<xref ref-type="bibr" rid="scirp.79350-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref18">18</xref>] . In Cameroon, the prevalence of coinfection with malaria and HIV among adolescence and adults has been reported to range between 2.24% to 29.4% [<xref ref-type="bibr" rid="scirp.79350-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref19">19</xref>] . But studies reporting the prevalence of coinfection with malaria and HIV in children are very limited in the country.</p><p>This study was therefore designed to determine the prevalence of coinfection with malaria and HIV among children in Yaound&#233;, in order to generate data for clinico-epidemiological purposes which will improve on the control of both diseases in the country.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Area</title><p>This study was performed in Yaound&#233; in the Centre region (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Yaound&#233; (3˚52'N 11˚31'E) with an average elevation of 750 m, is the capital of Cameroon. With a population of roughly 2.5 million, Yaound&#233; is second only to Douala as the largest city in Cameroon [<xref ref-type="bibr" rid="scirp.79350-ref20">20</xref>] . Yaound&#233; is a very diverse city with people from different works of life and is home to most of the administrative structures in the country. The climate of Yaound&#233; is tropical with 2 rainy (March to June, September to November) and 2 dry seasons (December to February, July-August). Malaria transmission in Yaound&#233; is holoendemic and seasonal with Anopheles gambiae as the principle vector [<xref ref-type="bibr" rid="scirp.79350-ref21">21</xref>] . According to hospital records, peak malaria transmission occurs at the beginning of the rainy seasons. The prevalence of malaria in the general population of Yaound&#233; is estimated at 35% [<xref ref-type="bibr" rid="scirp.79350-ref22">22</xref>] meanwhile the prevalence of HIV is estimated at 8.3% [<xref ref-type="bibr" rid="scirp.79350-ref10">10</xref>] .</p></sec><sec id="s2_2"><title>2.2. Study Design and Setting</title><p>This was a cross-sectional study performed between May and June 2017, involving children randomly selected from 3 communities in Yaound&#233;.</p></sec><sec id="s2_3"><title>2.3. Sample Size Estimation</title><p>The sample size was estimated using the formula for sample size calculation described by Swinscow [<xref ref-type="bibr" rid="scirp.79350-ref23">23</xref>] as follows;</p><p>n = Z 2 &#215; p ( 1 − p ) e 2</p><p>Z = 1.96</p><p>p = prevalence of malaria in children in Cameroon = 17.6% [<xref ref-type="bibr" rid="scirp.79350-ref7">7</xref>] .</p><p>e = error rate = 0.05</p><p>n = 1.96 2 &#215; 0.176 ( 1 − 0.176 ) 0.05 2 = 222 . 9</p><p>Thus we recruited 310 participants to adjust for possible loss of samples.</p></sec><sec id="s2_4"><title>2.4. Sampling Technique</title><p>Two stage sampling was done. In the first stage, 3 communities were randomly selected in Yaound&#233; including: Efoulan, Biyem-assi, and Cit&#233;-verte (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In the second stage, houses in the communities were randomly selected and children aged 15 years and below within selected houses were enrolled.</p></sec><sec id="s2_5"><title>2.5. Study Population</title><p>Children (≤15 years) of both sexes were eligible to participate in the study. The participants were recruited from 3 communities in Yaound&#233; namely: Efoulan, Biyem-assi and Cit&#233;-verte. Written informed consent was obtained from the parents or guidance of the children after explaining to them the study protocol and objectives. Excluded from the study were children not residing in the selected communities as well as those on any antimalarial drug 2 weeks prior to the study commencing.</p></sec><sec id="s2_6"><title>2.6. Ethical Consideration</title><p>Authorization to carry out this research was obtained from the Faculty of Health Sciences, University of Buea, and from the Delegation of Public Health, Yaound&#233;, Center region. Written informed consent was obtained from all participants prior to their inclusion.</p></sec><sec id="s2_7"><title>2.7. Data Collection</title><p>A semi-structured questionnaire was used to collect demographic characteristics (age, gender, etc.). The questionnaire was administered to the parents or guidance of the children by members of the research team.</p></sec><sec id="s2_8"><title>2.8. Sample Collection</title><p>About 3 ml of blood was collected from the children into EDTA anticoagulated tubes following antiseptic techniques. The blood was used to perform the complete blood count, preparation of blood films as well as screening for HIV.</p></sec><sec id="s2_9"><title>2.9. Laboratory Analysis</title><sec id="s2_9_1"><title>2.9.1. Performance of Complete Blood Count (CBC)</title><p>CBC was performed using the Mindray<sup>&#174;</sup> Auto haematology analyzer (BC-2800, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.). The white blood cell counts were obtained from the CBC results and used in the estimation of the parasite density.</p></sec><sec id="s2_9_2"><title>2.9.2. Detection of Malaria Parasite</title><p>The prepared blood films were air-dried and stained with 10% Giemsa (1 in 20 dilutions) for 25 - 30 minutes [<xref ref-type="bibr" rid="scirp.79350-ref24">24</xref>] . The blood films were read by two expert microscopists who were blinded from the results of the other. In the case of any discrepancy with the results obtained by the two microscopists, a third was brought in and the results he gave were considered as final. At least 200 fields were screened for malaria parasite using the 100X (oil immersion) objective and where parasites were seen, they were counted until 500 WBC were reached. The slides were only declared negative after counting to 2500 WBC. Malaria parasite density was estimated by dividing the parasites counted by 500 WBC and then multiplied by the actual WBC count of the participant to give numbers in parasite per μl [<xref ref-type="bibr" rid="scirp.79350-ref7">7</xref>] .</p></sec><sec id="s2_9_3"><title>2.9.3. Screening for HIV</title><p>HIV screening was done in accordance with the Cameroon’s national algorithm for HIV screening by detecting anti-HIV antibodies [<xref ref-type="bibr" rid="scirp.79350-ref25">25</xref>] . Briefly, a first line rapid test was used and if positive, a second line test was used to confirm the result as well as determine the HIV type. Where the first line test was positive and the second line test was negative, a third line test was brought in. In this study, the first line test used was Determine™ HIV (Abbott Laboratories, Abbott Park, IL, USA), the second line test was First Response<sup>&#174;</sup> (Kachigam, India) and the third line test was Immuno-Comb<sup>&#174;</sup> (Orgenics Ltd., Israel).</p></sec></sec><sec id="s2_10"><title>2.10. Statistical Analyses</title><p>Data collected was entered into Excel spreadsheet and analyzed using Stata<sup>&#174;</sup> version 12.1 (StataCorp LP) statistical package and group comparisons were performed using the Pearson’s Chi-square test. Statistical significance was set at p ≤ 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><p>Three hundred and ten (310) participants successfully took part in the study. Their ages ranged between 0 and 180 months, with mean (&#177;SD) = 75.64 (&#177;63.23) months. Among them were 136 (43.9%) females and 174 (56.1%) males (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Among the 310 participants, 61 were positive for malaria giving a prevalence of 19.7% (95% CI: 15.4 - 24.6). Malaria prevalence was associated with age (p = 0.01) but not with gender (p = 0.427) nor study site (p = 0.337) (<xref ref-type="table" rid="table2">Table 2</xref>). Plasmodium falciparum was the only species identified. There was no mixed infection with the other Plasmodium species.</p><p>Among the 310 participants, 15 were positive for HIV giving a prevalence of 4.8% (95% CI: 2.7 - 7.9). Fourteen (93.3 %) of the cases were HIV type 1 and 1 (6.7%) HIV type 2. HIV prevalence was associated with study site (p = 0.024) but not with age (p = 0.562) nor gender (p = 0.823) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Coinfection with malaria and HIV was observed in 4 of the 310 participants giving a prevalence of 1.2% (95% CI: 0.4 - 3.3) (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The distribution of the participants with respect to age, gender and study site</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="3"   rowspan="2"  >Study Site</th><th align="center" valign="middle"  colspan="3"  >Age (Month)</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >&lt;60</td><td align="center" valign="middle" >60 - 119</td><td align="center" valign="middle" >120+</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Biyem-assi</td><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >42</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >57</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >99</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Cite-verte</td><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >59</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >71</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >130</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Efoulan</td><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >35</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >46</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >81</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Total</td><td align="center" valign="middle"  rowspan="2"  >Gender</td><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >136</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >92</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >174</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >144</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >310</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> The prevalence of malaria and HIV stratified according to age, gender and study site</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Parameter</th><th align="center" valign="middle"  rowspan="2"  >N</th><th align="center" valign="middle"  colspan="3"  >Malaria</th><th align="center" valign="middle"  colspan="3"  >HIV</th></tr></thead><tr><td align="center" valign="middle" >Positive (%)</td><td align="center" valign="middle" >χ&#178;</td><td align="center" valign="middle" >p-value</td><td align="center" valign="middle" >Positive (%)</td><td align="center" valign="middle" >χ&#178;</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Age (Month)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >&lt;60</td><td align="center" valign="middle" >144</td><td align="center" valign="middle" >19 (13.2)</td><td align="center" valign="middle" >9.37</td><td align="center" valign="middle" >0.009</td><td align="center" valign="middle" >7 (4.9)</td><td align="center" valign="middle" >1.151</td><td align="center" valign="middle" >0.562</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >60 - 119</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >22 (30.6)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2 (2.8)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >≥120</td><td align="center" valign="middle" >94</td><td align="center" valign="middle" >20 (21.3)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >6 (6.4)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >M</td><td align="center" valign="middle" >174</td><td align="center" valign="middle" >37 (21.3)</td><td align="center" valign="middle" >0.632</td><td align="center" valign="middle" >0.427</td><td align="center" valign="middle" >8 (5.8)</td><td align="center" valign="middle" >0.050</td><td align="center" valign="middle" >0.823</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >F</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >24 (17.6)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >7 (6.3)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  colspan="2"  >Study site</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Biyem-assi</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >19 (19.2)</td><td align="center" valign="middle" >2.177</td><td align="center" valign="middle" >0.337</td><td align="center" valign="middle" >0 (0.0)</td><td align="center" valign="middle" >7.421</td><td align="center" valign="middle" >0.024</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cite-verte</td><td align="center" valign="middle" >130</td><td align="center" valign="middle" >20 (15.4)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >9 (6.9)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Efoulan</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >12 (14.8)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >6 (7.4)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>The prevalence of malaria in this study was 19.7%. The prevalence observed was lower than the malaria prevalence of 35% reported in the general population of Yaound&#233; [<xref ref-type="bibr" rid="scirp.79350-ref22">22</xref>] . This decrease in malaria prevalence in the current study could be attributed to the relentless effort by Cameroon’s government to reduce transmission through the distribution of insecticide-treated bed nets (ITNs) to every household in the country as well as the intense sensitization campaign through media [<xref ref-type="bibr" rid="scirp.79350-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref26">26</xref>] . The malaria prevalence in the current study was also lower compared to the national prevalence of 29% [<xref ref-type="bibr" rid="scirp.79350-ref27">27</xref>] .</p><p>In the current study, prevalence of malaria was higher in children aged between 60 and 119 months. The observation of a significant association between malaria prevalence and age corroborates studies performed elsewhere [<xref ref-type="bibr" rid="scirp.79350-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref29">29</xref>] , and this could be attributed to the playful attitude of children in this age group which exposes them to infective bites of mosquitoes. Conversely, prevalence of malaria in the current study was not observed to be associated with gender or study site. The finding of no association between prevalence of malaria and gender is in conformity with other studies [<xref ref-type="bibr" rid="scirp.79350-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.79350-ref7">7</xref>] .</p><p>Plasmodium falciparum was identified as the only species causing malaria in the target population, which is in line with the study by Kwenti et al. [<xref ref-type="bibr" rid="scirp.79350-ref7">7</xref>] , but contradictory to the study by Mbenda and Das [<xref ref-type="bibr" rid="scirp.79350-ref30">30</xref>] in which a prevalence of 4% for P. vivax infection was reported in Yaound&#233;. The differences in the study design may account for this discrepancy; our study targeted mainly children meanwhile theirs targeted adults and children.</p><p>The prevalence of HIV in the current study was 4.8%. This prevalence was not very different from the national prevalence of 4.5% [<xref ref-type="bibr" rid="scirp.79350-ref9">9</xref>] , but lower compared to the prevalence of 8.3% reported in the general population of Yaound&#233; [<xref ref-type="bibr" rid="scirp.79350-ref10">10</xref>] . Relative to prevalence in the general population of Yaound&#233;, the lower prevalence of HIV observed in this study could also be attributed to efforts by Cameroon’s government to control the disease largely through programs to prevent mother-to-child transmission as well as regular sensitization campaigns. There was an association between prevalence of HIV and study site in the current study, being highest in Efoulan (7.4%). An immediate explanation for this observation was not imminent. However, HIV prevalence in Cameroon has been reported to vary from one location to another and is influenced by the socio-cultural characteristics of the different populations. There was no association between HIV prevalence and age or gender in the current study.</p><p>The prevalence of coinfection with malaria and HIV observed in the current study was 1.2%. This finding is similar to the prevalence of 2.24% reported in Bamenda in the Northwest Region [<xref ref-type="bibr" rid="scirp.79350-ref19">19</xref>] . However, the prevalence of coinfection with malaria and HIV was lower than the 7.3% and 29.4% reported by Njunda et al. [<xref ref-type="bibr" rid="scirp.79350-ref16">16</xref>] and Nkuo-Akenji et al. [<xref ref-type="bibr" rid="scirp.79350-ref15">15</xref>] respectively. The difference in the prevalence of coinfection reported in these studies and ours could be attributed to differences in the study designs; our study targeted children in the community meanwhile theirs targeted known HIV patients recruited from HIV treatment facilities.</p><p>This study revealed the prevalence of malaria, HIV, and coinfection of malaria with HIV among children in 3 communities in Yaound&#233;. It has generated data that may be useful in designing control policies. The study is however limited in that participants were recruited from only 3 communities in Yaound&#233; and the findings may not be generalizable to the entire population of children in Yaound&#233;. Larger studies will therefore be required in the study area to give a clearer picture.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In the current study, a prevalence of 19.7%, 4.8%, and 1.2% was observed for malaria, HIV, and coinfection with malaria and HIV respectively. The prevalence of malaria was observed to be associated with age meanwhile the prevalence of HIV was associated with study site, being highest in Efoulan. Plasmodium falciparum was the only species identified as the cause of malaria in the target population. Efforts should be strengthened to control and eventually eliminate malaria and HIV in children in the study area.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Our sincere gratitude goes to all the children who voluntarily took part in this study.</p></sec><sec id="s7"><title>Competing Interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="s8"><title>Authors’ Contributions</title><p>This work was carried out in collaboration between all authors. TEK conceived the study; participated in its design, coordination and data collection; took part in the analyses and interpretation; conducted literature search and review; performed the statistical analysis and co-wrote the first draft. EE and BSA participated in the data collection, took part in the analyses and interpretation, conducted the literature search and review and co-wrote the first draft. TDBK conceived, designed and coordinated the study; participated in the statistical analysis; and critically revised the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="s9"><title>Cite this paper</title><p>Kwenti, T.E., Edo, E., Ayuk, B.S. and Kwenti, T.D.B. (2017) Prevalence of Coinfection with Malaria and HIV among Children in Yaound&#233;, Cameroon: A Cross-Sectional Survey Performed in Three Communities in Yaound&#233;. Yangtze Medicine, 1, 178-188. https://doi.org/10.4236/ym.2017.13018</p></sec></body><back><ref-list><title>References</title><ref id="scirp.79350-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation (2016) World Malaria Report 2016. World Health Organisation, Geneva. http://apps.who.int/iris/bitstream/10665/252038/1/9789241511711-eng.pdf?ua=1</mixed-citation></ref><ref id="scirp.79350-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation (2015) World Malaria Report 2015. World Health Organisation, Geneva. http://apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf?ua=1</mixed-citation></ref><ref id="scirp.79350-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Njunda, A.L., Fon, S.G., Assob, J.C.N., Nsagha, D.S., Kwenti, T.D.B. and Kwenti, E.T. (2015) Malaria and Intestinal Parasitic Coinfection and Their Contribution to Anaemia in Children in Cameroon. Infectious Diseases of Poverty, 4, 43.https://doi.org/10.1186/s40249-015-0078-5</mixed-citation></ref><ref id="scirp.79350-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kwenti, T.E., Nkume, F.A., Tanjeko, A.T. and Kwenti, T.D.B. (2016) The Effect of Intestinal Parasitic Infection on the Clinical Outcome of Malaria in Coinfected Children in Cameroon. PLoS Neglected Tropical Diseases, 10, Article ID: e0004673. https://doi.org/10.1371/journal.pntd.0004673</mixed-citation></ref><ref id="scirp.79350-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Kwenti, T.E., Kwenti, T.D.B., Latz, A., Njunda, L.A. and Nkuo-Akenji, T. (2017) Epidemiological and Clinical Profile of Paediatric Malaria: A Cross Sectional Study Performed on Febrile Children in Five Epidemiological Strata of Malaria in Cameroon. BMC Infectious Diseases, 17, 499. https://doi.org/10.1186/s12879-017-2587-2</mixed-citation></ref><ref id="scirp.79350-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation (2010) Cameroon: Epidemiological Profile. World Malaria Report. WHO, Geneva.</mixed-citation></ref><ref id="scirp.79350-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kwenti, T.E., Kwenti, T.D.B., Njunda, L.A., Latz, A., Tufon, K.A. and Nkuo-Akenji, T. (2017) Identification of the Plasmodium Species in Clinical Samples from Children Residing in Five Epidemiological Strata of Malaria in Cameroon. Tropical Medicine and Health, 45, 14. https://doi.org/10.1186/s41182-017-0058-5</mixed-citation></ref><ref id="scirp.79350-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">UNAIDS (2015a) Fact Sheet 2015. UNAIDS, Geneva. http://www.unaids.org/sites/default/files/media_asset/20150901_FactSheet_2015_en.pdf</mixed-citation></ref><ref id="scirp.79350-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">UNAIDS (2015b) Cameroon: Epidemiological Fact Sheet on HIV and AIDS. UNAIDS, Geneva.http://www.unaids.org/en/regionscountries/countries/cameroon/</mixed-citation></ref><ref id="scirp.79350-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Kwenti, T.E., Nsagha, D.S., Kwenti, B.D.T. and Njunda, A.L. (2014) Sexual Risk Behaviours among People Living with HIV and Implications for Control in the Northwest Region of Cameroon. World Journal of AIDS, 4, 198-205.https://doi.org/10.4236/wja.2014.42025</mixed-citation></ref><ref id="scirp.79350-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Kamya, M.R., Gasasira, A.F., Yeka, A., Bakyaita, N., Nsobya, S.L., Francis, D., et al. (2006) Effect of HIV-1 Infection on Antimalarial Treatment Outcomes in Uganda: A Population-Based Study. Journal of Infectious Disease, 193, 9-15. https://doi.org/10.1086/498577</mixed-citation></ref><ref id="scirp.79350-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Grimwade, K., French, N., Mbatha, D.D., Zungu, D.D., De-Dicoat, M. and Gilks, C.F. (2004) HIV Infection as a Cofactor for Severe Falciparum Malaria in Adults Living in a Region of Unstable Malaria Transmission in South Africa. AIDS, 18, 547-554. https://doi.org/10.1097/00002030-200402200-00023</mixed-citation></ref><ref id="scirp.79350-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Cohen, C., Karstaedt, A., Frean, J., Thomas, J., Govender, N., Prentice, E., et al. (2005) Increased Prevalence of Severe Malaria in HIV-Infected Adults in South Africa. Clinical Infection Disease, 41, 1631-1637. https://doi.org/10.1086/498023</mixed-citation></ref><ref id="scirp.79350-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Otieno, R.O., Ouma, C., Ong’echa, J.M., Keller, C.C., Were, T., Waindi, E.N., et al. (2006) Increased Severe Anemia in HIV-1-Exposed and HIV-1-Positive Infants and Children during Acute Malaria. AIDS, 20, 275-280. https://doi.org/10.1097/01.aids.0000200533.56490.b7</mixed-citation></ref><ref id="scirp.79350-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Nkuo-Akenji, T., Tevoufouet, E.M., Nzang, F., Ngufor, N. and Fon, E. (2008) High Prevalence of HIV and Malaria Co-Infection in Urban Douala, Cameroon. African Journal of AIDS Research, 7, 229-235. https://doi.org/10.2989/AJAR.2008.7.2.8.525</mixed-citation></ref><ref id="scirp.79350-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Njunda, A.L., Njumkeng, C., Nsagha, S.D., Assob, J.C.N. and Kwenti, E.T. (2016) The Prevalence of Malaria in People Living with HIV in Yaounde, Cameroon. BMC Public Health, 16, 964. https://doi.org/10.1186/s12889-016-3647-z</mixed-citation></ref><ref id="scirp.79350-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Saracino, A., Nacarapa, E.A., da Costa, M.E.A., Martinelli, D., Scacchetti, M., de Oliveira, C., et al. (2012) Prevalence and Clinical Features of HIV and Malaria Coinfection in Hospitalized Adults in Beira, Mozambique. Malaria Journal, 11, 241. https://doi.org/10.1186/1475-2875-11-241</mixed-citation></ref><ref id="scirp.79350-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tay, S.C.K., Badu, K., Mensah, A.A. and Gbedema, S.Y. (2015) The Prevalence of Malaria among HIV Seropositive Individuals and the Impact of the Co-Infection on Their Hemoglobin Levels. Annals of Clinical Microbiology and Antimicrobials, 14, 10. https://doi.org/10.1186/s12941-015-0064-6</mixed-citation></ref><ref id="scirp.79350-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Njunda, L.A., Kamga, H.L.F., Nsagha, D.S., Assob, J.C.N. and Kwenti, T.E. (2012) Low Malaria Prevalence in HIV-Positive Patients in Bamenda, Cameroon. Journal of Microbiology Research, 2, 56-59. https://doi.org/10.5923/j.microbiology.20120203.03</mixed-citation></ref><ref id="scirp.79350-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">World Gazetteer (2013) Cameroon: Largest Cities and Towns and Statistics of Their Population.</mixed-citation></ref><ref id="scirp.79350-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Craig, M., Snow, R. and le Sueur, D. (1999) A Climate-Based Distribution Model of Malaria Transmission in Sub-Saharan Africa. Parasitology Today, 15, 105-111. https://doi.org/10.1016/S0169-4758(99)01396-4</mixed-citation></ref><ref id="scirp.79350-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">van der Kolk, M., Etti T.A., Nimpaye, H., Ngo, N.D., Sauerwein, R. and Eling, W. (2003) Transmission of Plasmodium falciparum in Urban Yaoundé Cameroon Is Seasonal and Age-Dependent. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 375-379. https://doi.org/10.1016/S0035-9203(03)90059-9</mixed-citation></ref><ref id="scirp.79350-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Swinscow, T.D.V. and Campbell, M.J. (2002) Statistics at Square. 10th Edition, BMJ Books, London.</mixed-citation></ref><ref id="scirp.79350-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Njunda, A.L., Assob, N.J.C., Nsagha, S.D., Kamga, F.H.L., Mokenyu, M.D. and Kwenti, E.T. (2013) Comparison of Capillary and Venous Blood Using Blood Film Microscopy in the Detection of Malaria Parasites: A Hospital Based Study. Scientific Journal of Microbiology, 2, 89-94.</mixed-citation></ref><ref id="scirp.79350-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Sumbele, I.U.N., Ning, T.R., Bopda, O.S.M. and Nkuo-Akenji, T. (2014) Variation in Malariometric and Red Cell Indices in Children in the Mount Cameroon Area Following Enhanced Malaria Control Measures: Evidence from a Repeated Cross-Sectional Study. Malaria Journal, 13, 334. https://doi.org/10.1186/1475-2875-13-334</mixed-citation></ref><ref id="scirp.79350-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Kwenti, E.T., Njouom, R., Njunda, L.A. and Kamga, H.L.F. (2011) Comparison of an Immunochromatographic Rapid Strip Test, ELISA and PCR in the Diagnosis of Hepatitis C in HIV Patients in Hospital Settings in Cameroon. Clinical Medicine and Diagnostics, 1, 21-27. https://doi.org/10.5923/j.cmd.20110101.04</mixed-citation></ref><ref id="scirp.79350-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Mangham, L.J., Cundill, B., Achonduh, O.A., Ambebila, J.N., Lele, A.K., Metoh, T.N., et al. (2012) Malaria Prevalence and Treatment of Febrile Patients at Health Facilities and Medicine Retailers in Cameroon. Tropical Medicine and International Health, 17, 330-342.</mixed-citation></ref><ref id="scirp.79350-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Degarege, A., Legesse, M., Medhin, G., Animut, A. and Erko, B. (2012) Malaria and Related Outcomes in Patients with Intestinal Helminths: A Cross-Sectional Study. BMC Infectious Disease, 12, 291. https://doi.org/10.1186/1471-2334-12-291</mixed-citation></ref><ref id="scirp.79350-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Alemu, A., Shiferaw, Y., Ambachew, A. and Hamid, H. (2012) Malaria Helminth Co-Infections and Their Contribution for Anaemia in Febrile Patients Attending Azzezo Health Center, Gondar, Northwest Ethiopia: A Cross Sectional Study. Asian Pacific Journal Tropical Medicine, 5, 803-809. https://doi.org/10.1016/S1995-7645(12)60147-3</mixed-citation></ref><ref id="scirp.79350-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Ngassa, M.H.G. and Das, A. (2014) Molecular Evidence of Plasmodium Vivax Mono and Mixed Malaria Parasite Infections in Duffy-Negative Native Cameroonians. PLoS One, 9, e103262. https://doi.org/10.1371/journal.pone.0103262</mixed-citation></ref></ref-list></back></article>